Judith Klimovsky
Corporate Officer/Principal chez GENMAB A/S
Fortune : 3 M $ au 31/03/2024
Postes actifs de Judith Klimovsky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 09/02/2017 | - |
Historique de carrière de Judith Klimovsky
Anciens postes connus de Judith Klimovsky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Director/Board Member | 20/12/2018 | 23/02/2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01/05/2009 | 01/02/2017 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2009 | 01/01/2017 |
Formation de Judith Klimovsky
| University of Buenos Aires School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Suisse | 3 |
| Etats-Unis | 2 |
| Danemark | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| GENMAB A/S | Health Technology |
| Entreprise privées | 2 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
- Bourse
- Insiders
- Judith Klimovsky
- Expérience
